Literature DB >> 7950835

Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma.

A Jovanovic1, I G van der Tol, P J Kostense, E A Schulten, N de Vries, G B Snow, I van der Waal.   

Abstract

727 patients with squamous cell carcinoma (SCC) of the lip and oral cavity have been followed for the occurrence of second primary tumours (SPTs) in the respiratory and upper digestive tract (RUDT). 74 patients (10%) developed at least one SPT in the RUDT. The incidence of SPTs was expressed per 1000 person-years of follow-up. In our study about 28 SPTs per 1000 person-years of follow-up were seen in the RUDT. Patients were at risk for a second primary tumour, at a steady rate of approximately 2.8% per year during at least 10 years. Furthermore, patients with an index tumour in the lower part of the mouth (floor of mouth, retromolar area and lower alveolar process), which is more related to tobacco and/or alcohol, seem to be more at risk for SPTs than patients with an index tumour in the other (sub)sites of the mouth.

Entities:  

Mesh:

Year:  1994        PMID: 7950835     DOI: 10.1016/0964-1955(94)90001-9

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  9 in total

1.  FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.

Authors:  Yuko Suenaga; Kazuhiro Kitajima; Takeaki Ishihara; Ryohei Sasaki; Naoki Otsuki; Ken-Ichi Nibu; Tsutomu Minamikawa; Naomi Kiyota; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2015-07-19       Impact factor: 5.315

2.  Diagnostic sensitivity of ¹⁸fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients.

Authors:  Norio Kondo; Mamoru Tsukuda; Goshi Nishimura
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-09       Impact factor: 2.503

3.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

Review 4.  Molecular pathogenesis of oral squamous carcinoma.

Authors:  H K Williams
Journal:  Mol Pathol       Date:  2000-08

Review 5.  Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients.

Authors:  Chen-Shuan Chung; Li-Jen Liao; Chia-Yun Wu; Wu-Chia Lo; Chen-Hsi Hsieh; Tzong-His Lee; Chao-Yu Liu; Deng-Yu Kuo; Pei-Wei Shueng
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 6.  Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma.

Authors:  Bundhit Tantiwongkosi; Fang Yu; Anand Kanard; Frank R Miller
Journal:  World J Radiol       Date:  2014-05-28

7.  Second primary tumours in oropharyngeal squamous cell carcinoma.

Authors:  Franz-Josef Kramer; Marcel Janssen; Andre Eckardt
Journal:  Clin Oral Investig       Date:  2004-03-16       Impact factor: 3.573

8.  PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison.

Authors:  Sacha Rothschild; Gabriela Studer; Burkhardt Seifert; Pia Huguenin; Christoph Glanzmann; J Bernard Davis; Urs M Lütolf; Thomas F Hany; I Frank Ciernik
Journal:  Radiat Oncol       Date:  2007-06-09       Impact factor: 3.481

9.  (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.

Authors:  J W Kim; J-L Roh; J S Kim; J H Lee; K-J Cho; S-H Choi; S Y Nam; S Y Kim
Journal:  Br J Cancer       Date:  2013-10-22       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.